AGP Picks
View all

North Dakota Healthcare Newswire: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on North Dakota Healthcare Newswire.

Press releases published on November 11, 2026

J-Star Holding Reaffirms 50-Year Advanced Composite Craftsmanship and Executive Financial Commitment, Highlighted by Tier 1 Carbon Fiber Supplier Partnership and Automated U.S. UAV Production
ImpactLife Honors Service and Sacrifice of U.S. Veterans
CenTrak Launches Mobile Capability to Extend Staff Safety Beyond Hospital Walls
LightSolver to Unveil the First Public Demonstration of its All-Optical Computer at SC26
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference in London
aTyr Pharma to Participate in Upcoming Investor Conferences
America’s VetDogs and Veteran Pathways of New England Announce Partnership to Connect Veterans with Life-Changing Service Dogs
ImvivaBio Presents Longer-Term Data from Clinical Studies of CTA313 Allogeneic CAR-T Therapy in Lupus at the American College of Rheumatology Convergence 2026
Five Presentations, One Leading Innovation: Humacyte’s Acellular Tissue Engineered Vessel Takes Center Stage at VEITH 2026
Beacon Therapeutics to Participate in Jefferies 2026 Global Healthcare Conference in London
 BioAge Labs to Present at Upcoming Investor Conferences
Filana Therapeutics Names Biopharma Executive Jill M. Quigley to Board
Boston Concierge Orthopedics Launches New Website Highlighting Shoulder and Knee Care
Arcadia Honors Healthcare Leaders Driving Measurable Impact
Teva Shares Innovative Pipeline Updates and Unveils Path to Future Growth at R&D Day, Targeting $6–7 Billion in Innovative Medicines Revenue by 2030
PolyPid Provides Corporate Update and Reports Third Quarter 2026 Financial Results
Lycia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference
BridgeBio to Present New Acoramidis Data on Kidney Function, Real-World Outcomes, and First-Line Treatment Patterns in ATTR-CM at the International Symposium on Amyloidosis 2026
Dyne Therapeutics to Participate in Upcoming Investor Conference
MiNK Therapeutics Reports Third Quarter 2026 Results, First Pre-Commercial Product Revenue from agenT-797, Randomized ARDS Trial Advancing, and ARPA-H Selection for Deployable Cell Therapies

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

North Dakota Healthcare Newswire

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.